Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-746,127
Closed -$56.4M 5472
2026
Q1
$56.4M Buy
746,127
+277,107
+59% +$20.8M 0.01% 684
2025
Q4
$34.9M Buy
469,020
+1,206
+0.3% +$88.1K 0.01% 946
2025
Q3
$31.6M Sell
467,814
-257,266
-35% -$17.1M 0.01% 989
2025
Q2
$47.2M Sell
725,080
-76,964
-10% -$4.61M 0.01% 734
2025
Q1
$49.5M Buy
802,044
+281,970
+54% +$18.7M 0.01% 657
2024
Q4
$37.5M Sell
520,074
-198,157
-28% -$15.5M 0.01% 791
2024
Q3
$58.5M Buy
718,231
+231,578
+48% +$18.5M 0.02% 616
2024
Q2
$36.1M Sell
486,653
-182,522
-27% -$13.7M 0.01% 721
2024
Q1
$52.2M Buy
669,175
+117,746
+21% +$8.76M 0.02% 599
2023
Q4
$39.4M Buy
551,429
+126,295
+30% +$8.79M 0.01% 774
2023
Q3
$29.5M Sell
425,134
-157,628
-27% -$11.9M 0.02% 651
2023
Q2
$47.2M Buy
582,762
+77,068
+15% +$6.3M 0.03% 467
2023
Q1
$40.8M Buy
505,694
+3,205
+0.6% +$258K 0.02% 548
2022
Q4
$37.6M Buy
502,489
+82,048
+20% +$5.84M 0.02% 609
2022
Q3
$27.1M Sell
420,441
-156,386
-27% -$10.8M 0.03% 511
2022
Q2
$40M Buy
576,827
+55,175
+11% +$4.1M 0.02% 461
2022
Q1
$40.1M Sell
521,652
-51,715
-9% -$3.72M 0.03% 475
2021
Q4
$43.9M Sell
573,367
-39,897
-7% -$2.93M 0.02% 633
2021
Q3
$45.3M Buy
613,264
+180,633
+42% +$13.5M 0.02% 569
2021
Q2
$28.9M Buy
432,631
+92,360
+27% +$6.17M 0.01% 726
2021
Q1
$25.3M Buy
340,271
+106,698
+46% +$8.1M 0.01% 710
2020
Q4
$17M Buy
233,573
+36,033
+18% +$2.54M 0.01% 893
2020
Q3
$13.1M Buy
197,540
+1,769
+0.9% +$112K 0.01% 911
2020
Q2
$11.2M Sell
195,771
-85,228
-30% -$4.18M 0.01% 906
2020
Q1
$9.86M Sell
280,999
-395,222
-58% -$18.8M 0.01% 997
2019
Q4
$35.3M Sell
676,221
-370,302
-35% -$18.4M 0.02% 657
2019
Q3
$52.8M Buy
1,046,523
+484,391
+86% +$23.8M 0.03% 439
2019
Q2
$27M Buy
562,132
+81,446
+17% +$3.77M 0.02% 768
2019
Q1
$23.3M Buy
480,686
+175,008
+57% +$7.89M 0.02% 761
2018
Q4
$12.6M Sell
305,678
-108,698
-26% -$4.46M 0.01% 1019
2018
Q3
$17M Buy
414,376
+78,087
+23% +$3.16M 0.01% 946
2018
Q2
$13.4M Sell
336,289
-117,689
-26% -$4.53M 0.01% 1037
2018
Q1
$17M Buy
453,978
+94,742
+26% +$3.83M 0.01% 927
2017
Q4
$15.4M Sell
359,236
-56,499
-14% -$2.25M 0.01% 948
2017
Q3
$15.3M Buy
415,735
+49,275
+13% +$1.99M 0.02% 797
2017
Q2
$16.6M Buy
366,460
+136,694
+59% +$6.03M 0.02% 695
2017
Q1
$9.78M Sell
229,766
-2,839
-1% -$116K 0.01% 886
2016
Q4
$9.33M Buy
232,605
+183,829
+377% +$7.09M 0.01% 981
2016
Q3
$1.9M Sell
48,776
-1,391,695
-97% -$52.5M ﹤0.01% 2042
2016
Q2
$49.8M Buy
1,440,471
+1,061,459
+280% +$36.8M 0.06% 255
2016
Q1
$12.9M Buy
379,012
+265,185
+233% +$9.25M 0.02% 645
2015
Q4
$4.33M Buy
113,827
+43,499
+62% +$1.69M 0.01% 1424
2015
Q3
$2.74M Sell
70,328
-59,510
-46% -$2.36M ﹤0.01% 1849
2015
Q2
$4.93M Buy
129,838
+37,050
+40% +$1.3M 0.01% 1491
2015
Q1
$3.06M Sell
92,788
-121,225
-57% -$3.72M ﹤0.01% 1943
2014
Q4
$5.56M Sell
214,013
-84,301
-28% -$2.18M 0.01% 1617
2014
Q3
$7.16M Buy
298,314
+1,336
+0.4% +$33.7K 0.01% 1453
2014
Q2
$7.43M Buy
296,978
+6,051
+2% +$141K 0.01% 1386
2014
Q1
$6.11M Sell
290,927
-408,902
-58% -$8.82M 0.01% 1551
2013
Q4
$15.4M Sell
699,829
-117,852
-14% -$2.6M 0.02% 937
2013
Q3
$16.4M Buy
817,681
+639,511
+359% +$13.6M 0.02% 796
2013
Q2
$3.44M Buy
+178,170
New +$3.72M ﹤0.01% 1956

Other funds holding HOLX

Barclays's HOLX Position: Q2 2026 in Review

Barclays sold out of Hologic (HOLX) in Q2 2026, closing a stake of 746,127 shares — an estimated $56.4M sold.

Barclays first reported a position in HOLX in Q2 2013 and held it in 52 quarters. The position peaked at $58.5M in Q3 2024. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Barclays reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Barclays sold 746,127 Hologic shares in Q2 2026, an estimated $56.4M.
  • Barclays first reported a position in Hologic in Q2 2013 and held it in 52 quarters.
  • Barclays's Hologic position peaked at $58.5M in Q3 2024.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.